The impact of the COVID-19 pandemic on diagnosis and treatment of patients with soft tissue and bone sarcomas or aggressive benign musculoskeletal diseases: A single-center retrospective study (SarCorD study)

BACKGROUND: The COVID-19 pandemic led to a rapid reorganization of healthcare activities, leading to reduced access to clinics, interruption of screenings, and treatment schedule modifications in several cancer types. Few data are available on sarcomas. We analyzed COVID-19-related diagnostic delay...

Descripción completa

Detalles Bibliográficos
Autores principales: Onesti, Concetta Elisa, Vari, Sabrina, Nardozza, Francesca, Maggi, Gabriella, Minghelli, Denise, Rossi, Barbara, Sperati, Francesca, Checcucci, Elisa, Faltyn, Wioletta, Cercato, Maria Cecilia, Cosimati, Antonella, Biagini, Roberto, Ciliberto, Gennaro, Ferraresi, Virginia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559379/
https://www.ncbi.nlm.nih.gov/pubmed/36249051
http://dx.doi.org/10.3389/fonc.2022.1000056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559379/
https://www.ncbi.nlm.nih.gov/pubmed/36249051
http://dx.doi.org/10.3389/fonc.2022.1000056

Ejemplares similares